March 8, 2020 | .

FDA Issues Boxed Warning for Allergy Drug Singulair

A new FDA boxed warning cautions against prescribing the asthma and allergy drug Singulair for people with mild symptoms, including those with hay fever. FDA officials say the potential for serious side effects from Singulair includes mental health issues such as suicidal thoughts.
FDA Issues Boxed Warning for Allergy Drug Singulair

Time & Location

March 8, 2020
.

Share this event